Pistoia Alliance Conference: Collaborative R&D in Action

April 20-21 & 23, 2021 

 

2021 will be another pivotal year for collaboration in life sciences R&D. Join us for our live, interactive virtual conference as we come together as a community, collaborating to solve common problems and to drive innovation across the ever-changing life sciences ecosystem. Explore themes including collaborative research and innovation, decentralised clinical trials, precision medicine and women in STEM.

  • Inspiring keynote presentations from top pharma R&D leaders
  • Interactive debates and fireside chats with industry thought leaders
  • Unique networking opportunities
  • Collaborative R&D in action showcase including highlights from our developing projects
laptop.png
Use your company email address to complete the form below and register for this free conference.

30+ Industry Leaders

Presentations, panel discussions, and virtual networking will provide stimulus and opportunity for discussions to identify key areas where the Pistoia Alliance can set up collaborative projects that will drive innovation and make a real difference to research and ultimately to patients.

Explore Member Benefits
21CONF_lp-keynote-sponsor
PA-VCW-Oct2020_300x250_LotF-02

Lab of the Future

The Lab is the centre of innovation but the role and nature of the Lab has changed. These changes are being driven by advances in life science research, technology and latterly, COVID-19. What are the latest developments in workspace, facilities planning and technology? How is the science being done now and what will the Lab of Future look like?

PA-VCW-Oct2020_300x250_LotF

Emerging Science and Technology

Explore and review how innovative science and technology is disrupting and transforming the way R&D is being conducted in a number of forward thinking life science organisations.

PA-VCW-Oct2020_300x250_drug-dev

Application of Real World Data (RWD) in Drug Discovery & Development

Explore how RWD can be used to improve the efficiency and effectiveness of drug discovery and development including data governance, infrastructure requirements, and multi-stakeholder Real World Evidence generation.